BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Health Decisions CEO Explores High-Velocity Adaptive Clinical Research June 23 at DIA


6/9/2009 1:36:55 PM

(Durham, NC: June 9, 2009) Health Decisions (www.healthdec.com, Booth 1447), a full-service clinical research organization (CRO) specializing in high-efficiency adaptive solutions, announces that President and CEO Michael Rosenberg, MD, MPH will lead a paneled session June 23 at the DIA Annual Meeting in San Diego. The Practice of Adaptive Research will focus on the pragmatic aspects of planning and managing complete adaptive programs – including the balance between mid-trial adjustments to both design and operations; the technology platform required to support these programs; and the broader implications of adaptive decision-making to the global pharmaceutical market.

According to Rosenberg, rising development costs, reimbursement pressures, and the global economic environment make the time- and cost-saving benefits of adaptive clinical research more important than ever. “Applying adaptive principles to study design as well as day-to-day operations presents an immediate promise of a dramatically faster, more efficient development pathway,” says Rosenberg. “We can eliminate poor candidates earlier, get good products to market faster, and make it financially attractive to focus on smaller, more individualized populations, including individualized therapies.”

The Practice of Adaptive Research will include the following presentations from industry experts:

• “Operational Adaptations: Running Tighter, Faster Studies,” presented by Mike Ford, director of data management at Health Decisions

• “Drug Supply in Adaptive Studies,” presented Michael Krams, MD, vice president of Adaptive Trials and Applied Program Strategies at Wyeth

• "Statistical Issues,” presented by Roger J. Lewis, MD, PhD, Professor of Medicine, Department of Emergency Medicine at Harbor UCLA Medical Center

• “Financial Benefits of Adaptive,” presented by Michael Rosenberg, MD, MPH, president and CEO of Health Decisions

The Practice of Adaptive Research is part of the R&D Strategy (RD) track, and takes place June 23 from 10:00 – 11:30 a.m. PST in Room 14B. To view the abstract, please visit http://www.diahome.org/DIAHOME/FlagshipMeetings/SearchSesTut.aspx?productID=18912&rpex=N&evtyp=SESSION&chr=Michael&ia=ALL&meetingid=17194.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES